Kiri Industries FY26: DyStar Money, Copper Dreams, Chemicals Fumbling

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1. At a Glance

FY26 is less a year and more a plot twist. Kiri closed out a decade-long legal brawl with DyStar, pocketed ₹6,195 crore in proceeds, and suddenly found itself holding capital like a chemistry company that accidentally bought an oil rig.

The standalone dyes-chemicals business? Decent recovery, but holding its own against raw material headwinds. Consolidated revenue grew 13% to ₹840 crore. But net profit swung wildly into ₹557 crore—not because operations got that good, but because DyStar’s ₹5,881 crore exceptional gain rewrote the arithmetic entirely.

Strip out the DyStar windfall and the company’s core business logic looks familiar: EBITDA is barely positive. The adjusted standalone EBITDA sits at ₹79 crore on ₹778 crore sales. A 10% margin picture, not a double-digit one.

The real headline: what comes next. With ₹13,000 crore committed to a copper-plus-fertilizer mega-project, Kiri has pivoted from defending a minority stake to building factories that don’t exist yet. First copper comes online in FY27–28. Till then, watch the balance sheet load with capex debt and working capital lines.

2. Introduction

Kiri Industries is a 27-year-old, Gujarat-rooted dyes-and-chemicals exporter. For a decade it was defined by its DyStar legal war—a 37.5% minority stake entangled in a Singapore courtroom with majority shareholder Senda International (backed by China’s Longsheng Group).

June 2026 changed the game. The Singapore International Commercial Court ordered a full sale of DyStar. On December 31, 2025, Kiri received ₹6,195 crore for its stake. The verdict? Kiri wins on oppression and fraud charges. The arithmetic? Enough cash to fund a greenfield copper refinery and phosphate-fertilizer plant.

FY26 results were audited and approved on May 30, 2026. CMP as of mid-June sits at ₹400.45 (prices referenced are not live). Promoter holding has climbed to 41.71%, up from 36.72% a year earlier, via warrant conversions.

3. Business Model: WTF Do They Even Do?

Kiri makes three things: dyes, dye intermediates, and basic chemicals—all shipped from two clusters in Gujarat (Ahmedabad and Vadodara) to 50+ countries.

Dyes (33% of FY26 revenue): Reactive, acid, direct, disperse dyes used in textiles and leather. Commodities with shelf lives that don’t forgive inventory goofs. Pricing is brutal; supply from China until recently was an avalanche.

Dye Intermediates (52% of FY26): H-acid, aniline, naphthalene, vinyl sulphone—the raw chemistry that dye makers buy to synthesize final dyes. More stable margins than dyes, but still hostage to oil prices and Chinese supply curves. Management says China’s recent tightening on environmental grounds has been a tailwind.

Basic Chemicals (15% of FY26): Sulphuric acid, oleum, chloro-sulphonic acid. Industrial commodities sold to pharma, fertilizers, auto batteries, paper mills. Bulk, low-margin, thick volume. This bucket is growing because management sees the mix as a hedge against dye volatility.

The company operates five plants with a collective capacity of 182,500 MTPA (basic chemicals), 25,200 MTPA (commodity intermediates), 7,200 MTPA (H-acid), and ~44,000 MTPA (reactive and disperse dyes combined). Actual utilization last year hovered in the 40–50% range—a polite way of saying factories had slack.

Exports are 44% of sales; domestic is 56%. The company is India-first by geography but global-reach by product design. Its competitive edge is execution and cost discipline, not exclusive IP or brand pricing power. Margin depends on whether the company can undercut Chinese supply or if raw material costs eat the spread.

4. Financials Overview

Figures are consolidated, in ₹ crore.

Quarterly Snapshot (Last 4 Quarters)

Annual View (3 Years)

Revenue grew 13% YoY, driven by improved volumes and better pricing in intermediates. EBITDA turned negative on the back of raw material cost pressures and ₹114 crore in non-cash “closing-period measurement transactions” (a euphemism for fair-value mark-to-market adjustments on hedging and parking of excess cash). Excluding those MTM items, adjusted EBITDA would be ₹79 crore on ₹778 crore standalone sales—a 10% margin.

Net profit is an optical illusion. The ₹557 crore PAT is dominated by a ₹5,881 crore exceptional gain from DyStar’s sale and writeoffs of past trade receivables. Core profitability remains under stress.

Earnings Per Share Note

FY26 reported EPS is ₹927 (both basic and diluted as reported at 954 and 914 respectively in standalone). This calculation used the full-year net profit divided by 6.52 crore weighted average shares. Q4 alone carried ₹513 crore due to tax reversals (the DyStar settlement had deferred tax impacts); Q1–Q3 were collectively ₹24 crore—or ₹2–3 per share at quarterly run rates.

5. Market Expectations & Historical Multiples

This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.

The market currently pays ₹400.45 per share against a book value of ₹1,072 per share (as of March 2026)—a discount of 63%. Historically, Kiri has traded at 9.35x P/E over five years; the peer median sits at 18.6x, suggesting the company has traded at a discount to comparable dyes-and-chemicals firms.

Current profitability metrics are negative (ROE –2%, ROCE –2%), a reversal from the 10-year average ROE of 10% and the 5-year average of 5.26%. The cash pile from DyStar has inflated the book value sharply—from ₹65 crore in reserves (FY25) to ₹632 crore (FY26 standalone).

What is the market pricing in? A combination of near-term uncertainty around the new copper project (no revenue until FY27–28, large capex ahead), the fragility of core dyes margins, and perhaps a wait-and-see on management’s ability to execute a ₹13,000 crore industrial build without capital discipline lapses. The discount to peer multiples also reflects the company’s scale (₹840 crore consolidated revenue vs. peers at ₹655–9,787 crore) and historical return volatility.

No target price, no implied valuation, no model-based arithmetic. The facts: the market is pricing the company at a 63% discount to book and 0.37x price-to-book ratio, significantly below historical peer multiples and its own 5-year median multiple.

6. What’s Cooking

DyStar Monetization (Closed, ₹6,195 Crore) The Singapore court ordered a full en-bloc sale. Kiri received its proceeds in full on December 31, 2025—₹6,195 crore (USD 689 million). The case involved oppression, fraud, and breach of trust claims. Senda International (Longsheng’s subsidiary), the majority shareholder, agreed to cover Kiri’s legal costs. Kiri’s investment was recognized as an associate until Q2 FY26; the company’s 40% share in Lonsen Kiri (a dyes JV in Jiangsu, China) continues to contribute ₹58 crore to consolidated PAT.

Integrated Copper & Fertilizer Complex (₹13,000 Crore Capex, FY27–FY29) Management is building a 1 million TPA copper smelter-refinery